Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OTU domain-containing protein 7B (Human) | BDBM443363![]() (7-(1-Methyl-1H-indazol- 4-yl)-2-oxo-1,2- dihydrosp...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443372![]() (7-(5-Methyl-1H- indazol-4-yl)-2- oxo-1,4-dihydro- ...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443364![]() (7-(1-(2-Hydroxyethyl)- 1H-indazol-4-yl)-2- oxo-1,2...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443362![]() (7-(1H-Indazol-4-yl)-2- oxo-1,2-dihydrospiro [pyrid...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443251![]() (7'-(1-Methyl-1H-indazol-5-yl)- 2'-oxo-1',4'-dihydr...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443287![]() (US10654853, Example 60) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443346![]() (N-(2-(1-Cyano-2'-oxo-1',4'-dihydro- 2'H-spiro[pyrr...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443370![]() (1′-Cyano-2-oxo-N-phenyl-1,2-dihydrospiro[pyr...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443246![]() (7'-(4-(4-Methylpiperazin-1- yl)phenyl)-2'-oxo-1',4...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443255![]() (2'-Oxo-7'-(pyrimidin-5-yl)- 1',4'-dihydro-2'H- spi...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443268![]() (US10654853, Example 41 | US10654853, Example 44) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443268![]() (US10654853, Example 41 | US10654853, Example 44) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443299![]() ((S)-7-(4- Fluorophenyl)- 2-oxo-1,4- dihydro-2H- sp...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443300![]() ((S)-7-(3- Fluorophenyl)- 2-oxo- 1,4-dihydro- 2H-sp...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443314![]() (8-Methyl-7,10-dioxo-8-phenyl-2,6,9-triazaspiro[4.5...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443321![]() (6'-(1-Methyl-1H-pyrazol-5-yl)-2'-oxo- 1',4'-dihydr...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443348![]() (6'-(3-(Morpholinosulfonyl)phenyl)-2'- oxo-1',4'-di...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443353![]() (6'-(4-(4-Methylpiperazin-1-yl)phenyl)- 2'-oxo-1',4...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443356![]() (6'-(4-(Morpholinomethyl)phenyl)-2'- oxo-1',4'-dihy...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443365![]() (7-(6-Methoxy-2- methylpyridin-3-yl)- 2-oxo-1,2-dih...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443367![]() (7-(1-(2-Methoxyethyl)-1H-indazol-4-yl)-2-oxo-1,2-d...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443276![]() (2-Oxo-7-phenyl-1,2-dihydrospiro[pyrido[2,3-b][1,4]...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443277![]() (7-(4-Cyanophenyl)-2-oxo- 1,2-dihydrospiro[pyrido [...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443286![]() (US10654853, Example 59) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443301![]() ((S)-7-(4- Fluorophenyl)- 2-oxo-1,2- dihydrospiro [...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443302![]() ((S)-7-(3-Cyanophenyl)-2-oxo-1,4-dihydro-2H-spiro[p...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443313![]() (2-Oxo-1,2,4,5-tetrahydrospiro[pyrido[2,3-b][1,4]di...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443320![]() (6'-(4-(Benzyloxy)phenyl)-2'-oxo-1',4'- dihydro-2'H...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443324![]() (6'-(1-Methyl-1H-pyrazol-4-yl)-2'-oxo- 1',4'-dihydr...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443330![]() (6'-(6-Methoxypyridin-3-yl)-2'-oxo- 1',4'-dihydro-2...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443337![]() (4-(1-Cyano-2'-oxo-1',4'-dihydro-2'H- spiro[pyrroli...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443340![]() (N-(4-(1-Cyano-2'-oxo-1',4'-dihydro- 2'H-spiro[pyrr...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443350![]() (6'-(2-Methylbenzo[d]thiazol-5-yl)-2'- oxo-1',4'-di...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443354![]() (N-Benzyl-4-(1-cyano-2'-oxo-1',4'- dihydro-2'H-spir...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443366![]() (6-(1H-Indazol-4-yl)-2-oxo-1,2-dihydrospiro[pyrido[...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443250![]() (7'-(4-(4-Methylpiperazine-1- carbonyl)phenyl)-2'-o...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443284![]() (US10654853, Example 57) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443293![]() ((S)-2-Oxo-1,4- dihydro-2H- spiro[pyrido[2,3- b]pyr...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443294![]() ((R)-2'-Oxo-6'- phenyl-1',4'- dihydro-2'H- spiro[py...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443296![]() ((S)-7-(3- Fluorophenyl)- 2-oxo-1,2- dihydrospiro [...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443328![]() (6'-(5-Isopropyl-2-methoxyphenyl)-2'- oxo-1',4'-dih...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443335![]() (6'-(5-Methyl-1H-indazol-4-yl)-2'-oxo- 1',4'-dihydr...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443339![]() (N-(3-(1-Cyano-2'-oxo-1',4'-dihydro- 2'H-spiro[pyrr...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443342![]() (6'-(1-Methyl-1H-pyrrol-2-yl)-2'-oxo- 1',4'-dihydro...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443245![]() (7'-(3-((2- Chlorobenzyl)oxy)phenyl)-2'- oxo-1',4'-...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443272![]() (6'-(3-Fluorophenyl)- 2'-oxo-1',4'-dihydro- 2'H-spi...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443278![]() (7-(3-Cyanophenyl)-2-oxo- 1,2-dihydrospiro[pyrido [...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443291![]() ((S)-2-Oxo-7-phenyl-1,2-dihydrospiro[pyrido[2,3-b][...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443297![]() ((S)-7-(4- Cyanophenyl)- 2-oxo-1,2- dihydrospiro [p...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443343![]() (6'-(4-(Morpholinosulfonyl)phenyl)-2'- oxo-1',4'-di...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443344![]() (6'-(3,5-Dimethyl-1H-pyrazol-4-yl)-2'- oxo-1',4'-di...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443347![]() (6'-(4-(Morpholine-4-carbonyl)phenyl)- 2'-oxo-1',4'...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443373![]() (7-(1,4-Dimethyl-1H- pyrazol-5-yl)-2-oxo- 1,4-dihyd...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443243![]() (7'-(2-(Benzyloxy)phenyl)-2'- oxo-1',4'-dihydro-2'H...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443248![]() (7'-(5-Fluoro-2- isopropoxyphenyl)-2'-oxo- 1',4'-di...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443249![]() (7'-(3-Methyl-1H-indazol-6-yl)- 2'-oxo-1',4'-dihydr...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443252![]() (7'-(5-Methyl-1H-indazol-4-yl)- 2'-oxo-1',4'-dihydr...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443269![]() (6'-(4-Cyanophenyl)- 2'-oxo-1',4'-dihydro- 2'H-spir...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443279![]() (7-(4-Fluorophenyl)-2-oxo- 1,2-dihydrospiro[pyrido ...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443280![]() (7-(3-Fluorophenyl)-2-oxo- 1,2-dihydrospiro[pyrido ...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443295![]() ((S)-2-Oxo-7- phenyl- 1,4-dihydro-2H- spiro[pyrido[...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443332![]() (6'-(3-Methyl-1H-indazol-6-yl)-2'-oxo- 1',4'-dihydr...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443345![]() (2'-Oxo-6'-(3-(piperidin-1-yl)phenyl)- 1',4'-dihydr...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443351![]() (6'-(3,5-Dimethylisoxazol-4-yl)-2'-oxo- 1',4'-dihyd...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443270![]() (6'-(3-Cyanophenyl)- 2'-oxo-1',4'-dihydro- 2'H-spir...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443275![]() (US10654853, Example 48) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443298![]() ((S)-7-(3- Cyanophenyl)- 2-oxo-1,2- dihydrospiro [p...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443317![]() (7'-(3-(4-Methylpiperazine-1- carbonyl)phenyl)-2'-o...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443322![]() (2'-Oxo-6'-(3- (trifluoromethoxy)phenyl)-1',4'- dih...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443325![]() (5-(1-Cyano-2'-oxo-1',4'-dihydro-2'H- spiro[pyrroli...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443334![]() (6'-(1-Methyl-1H-indazol-5-yl)-2'-oxo- 1',4'-dihydr...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443336![]() (N-(3-(1-Cyano-2'-oxo-1',4'-dihydro- 2'H-spiro[pyrr...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443338![]() (2'-Oxo-6'-(pyrimidin-5-yl)-1',4'- dihydro-2'H-spir...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443341![]() (6'-(3-(4-Methylpiperazine-1- carbonyl)phenyl)-2'-o...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443355![]() (6'-(3-Methyl-1H-pyrazol-4-yl)-2'-oxo- 1',4'-dihydr...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443357![]() (3-(1-Cyano-2'-oxo-1',4'-dihydro-2'H- spiro[pyrroli...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443359![]() ((R)-7′-(5-Methyl-H-indazol-4-yl)-2′-ox...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443360![]() (7′-(1H-Indazol-4-yl)-2′-oxo-1′,4...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443371![]() (1′-Cyano-N-(2-fluorophenyl)-2-oxo-1,2-dihydr...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443253![]() (N-(3-(1-Cyano-2'-oxo-1',4'- dihydro-2'H- spiro[pyr...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443267![]() (7'-(2-Methylbenzo[d]thiazol- 5-yl)-2'-oxo-1',4'-di...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443281![]() (2-Oxo-6-phenyl-1,2-dihydrospiro[pyrido[2,3-b][1,4]...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443285![]() (7-(4-Cyanophenyl)-2- oxo-1,4-dihydro-2H- spiro[pyr...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443327![]() (4-(1-Cyano-2'-oxo-1',4'-dihydro-2'H- spiro[pyrroli...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443331![]() (6'-(5-Fluoro-2-isopropoxyphenyl)-2'- oxo-1',4'-dih...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443352![]() (6'-(2-Chloro-5- (trifluoromethoxy)phenyl)-2'-oxo-1...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443358![]() (6'-(2-Methylpyridin-4-yl)-2'-oxo-1',4'- dihydro-2'...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443361![]() (6′-(1H-Indazol-4-yl)-2′-oxo-1′,4...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443257![]() (3-(1-Cyano-2'-oxo-1',4'- dihydro-2'H- spiro[pyrrol...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443263![]() (N-(2-(1-Cyano-2'-oxo-1',4'- dihydro-2'H- spiro[pyr...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443316![]() (4-(1-Cyano-2'-oxo-1',4'- dihydro-2'H- spiro[pyrrol...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443244![]() (4-(1-Cyano-2'-oxo-1',4'- dihydro-2'H- spiro[pyrrol...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443247![]() (7'-(6-Methoxypyridin-3-yl)-2'- oxo-1',4'-dihydro-2...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443266![]() (7'-(1-Methyl-6-oxo-1,6- dihydropyridin-3-yl)-2'-ox...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443273![]() (1-Cyano-N,N-dimethyl-2′-oxo-1′,4′...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443274![]() (1-Cyano-N-methyl-2′-oxo-1′,4′-di...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443306![]() (7,10-Dioxo-8-phenyl-2,6,9-triazaspiro[4.5]decane-2...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443349![]() (6'-(1-Methyl-6-oxo-1,6-dihydropyridin- 3-yl)-2'-ox...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443369![]() (2-Oxo-6-(piperidine-1-carbonyl)-1,2-dihydrospiro[p...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443232![]() (US10654853, Example 5) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443241![]() (7'-(2-Chloro-5- (trifluoromethoxy)phenyl)-2'- oxo-...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443254![]() (7'-(3-Methyl-1H-pyrazol-4- yl)-2'-oxo-1',4'-dihydr...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443256![]() (N-(3-(1-Cyano-2'-oxo-1',4'- dihydro-2'H- spiro[pyr...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443262![]() (2'-Oxo-7'-(3-(piperidin-1- yl)phenyl)-1',4'-dihydr...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443283![]() (2-Oxo-6-(trifluoromethyl)-1,4-dihydro-2H-spiro[pyr...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443304![]() (7,10-Dioxo-2,6,9-triazaspiro[4.5]decane-2-carbonit...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443305![]() ((8S)-8-Methyl-7,10-dioxo-2,6,9-triazaspiro[4.5]dec...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443230![]() (US10654853, Example 3) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443239![]() (7'-(1-Methyl-1H-pyrazol-4- yl)-2'-oxo-1',4'-dihydr...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443235![]() (7'-(2-Fluoro-5-methylphenyl)- 2'-oxo-1',4'-dihydro...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443368![]() (1′-Cyano-N-(4-fluorophenyl)-2-oxo-1,2-dihydr...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443333![]() (6'-(4-(4-Methylpiperazine-1- carbonyl)phenyl)-2'-o...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443229![]() (US10654853, Example 2) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443288![]() (3-Oxo-3,4-dihydro-1H-spiro[pyrido[2,3-b]pyrazine-2...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443292![]() ((S)-2-Oxo-1,2- dihydrospiro [pyrido[2,3- b][1,4]ox...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443323![]() (2'-Oxo-6'-(4-phenoxyphenyl)-1',4'- dihydro-2'H-spi...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443329![]() (6'-(3-((2-Chlorobenzyl)oxy)phenyl)-2'- oxo-1',4'-d...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443374![]() (2-Oxo-6-phenyl-1,4-dihydro-2H-spiro[pyrido[2,3-b]p...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443238![]() (2'-Oxo-7'-(4-phenoxyphenyl)- 1',4'-dihydro-2'H- sp...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443242![]() (5-(1-Cyano-2'-oxo-1',4'- dihydro-2'H- spiro[pyrrol...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443258![]() (N-(4-(1-Cyano-2'-oxo-1',4'- dihydro-2'H- spiro[pyr...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443265![]() (7'-(3- (Morpholinosulfonyl)phenyl)- 2'-oxo-1',4'-d...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443326![]() (6'-(2-(Benzyloxy)phenyl)-2'-oxo-1',4'- dihydro-2'H...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443231![]() (US10654853, Example 4) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443234![]() (7'-(4-(Benzyloxy)phenyl)-2'- oxo-1',4'-dihydro-2'H...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443236![]() (7'-(3-Cyanophenyl)-2'-oxo- 1',4'-dihydro-2'H- spir...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443237![]() (7'-(1-Methyl-1H-pyrazol-5- yl)-2'-oxo-1',4'-dihydr...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443240![]() (7'-(4-Cyanophenyl)-2'-oxo- 1',4'-dihydro-2'H- spir...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443282![]() (US10654853, Example 55) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443303![]() ((8R)-8-Methyl-7,10-dioxo-2,6,9-triazaspiro[4.5]dec...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443312![]() (2-Oxo-1,5-dihydro-2H-spiro[benzo[e][1,4]oxazepine-...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443315![]() (2'-Oxo-7'-(3- (trifluoromethoxy)phenyl)- 1',4'-dih...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443318![]() (7'-(1-Methyl-1H-pyrrol-2-yl)- 2'-oxo-1',4'-dihydro...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443264![]() (7'-(4-(Morpholine-4- carbonyl)phenyl)-2'-oxo-1',4'...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443290![]() ((R)-6-Oxo-2,7-diazaspiro[4.4]nonane-2-carbonitrile...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443219![]() (US10654853, Example 1) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443233![]() (7'-([1,1'-Biphenyl]-4-yl)-2'- oxo-1',4'-dihydro-2'...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443259![]() (7'-(4- (Morpholinosulfonyl)phenyl)- 2'-oxo-1',4'-d...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443260![]() (7'-(3,5-Dimethyl-1H-pyrazol- 4-yl)-2'-oxo-1',4'-di...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443261![]() (7'-(2-Methylpyridin-4-yl)-2'- oxo-1',4'-dihydro-2'...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443308![]() (8-Benzyl-6-oxo-2,7-diazaspiro[4.4]nonane-2-carboni...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443319![]() (6'-([1,1'-Biphenyl]-4-yl)-2'-oxo-1',4'- dihydro-2'...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443309![]() (US10654853, Example 82 | US10654853, Example 83) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443289![]() (6-Oxo-2,7-diazaspiro[4.4]nonane-2-carbonitrile | U...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443309![]() (US10654853, Example 82 | US10654853, Example 83) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443311![]() (6-Oxo-8-phenyl-2,7-diazaspiro[4.4]nonane-2-carboni...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443307![]() (8-Ethyl-6-oxo-2,7-diazaspiro[4.4]nonane-2-carbonit...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) | |||||||||||
More data for this Ligand-Target Pair |